|Basis of Allotment|
is only an advertisement for Information purpose. This is not a Prospectus announcement
and does not constitute an invitation or offer to acquire, purchase or subscribe for
securities. Not for publication or distribution, directly or indirectly outside India.)
SAKAR HEALTHCARE LIMITED
Our Company was incorporated as "Sakar Healthcare Private Limited" at Ahmedabad, Gujarat as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated March 26, 2004 bearing corporate identification number U24231GJ2004PTC043861 issued by Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, our Company was converted into public company pursuant to shareholders resolution passed in the Extraordinary General Meeting held on March 09, 2015 and the Company was converted into a public limited Company vide fresh certificate of incorporation issued on March 27,2015 by Registrar of Companies, Gujarat, Ahmedabad and the name of our Company was changed to "Sakar Healthcare Limited". For details of incorporation.change of name and registered office of our Company, please refer to chapter titled "General Information" and "Our History and Certain Other Corporate Matters" beginning on page 58 and 170 respectively of the Prospectus.
Registered Office: Plot No. 10/13, Nr. M N. Desai Petrol Pump,
Sarkhej Bavla Highway, Changodar, Ahmedabad - 382 213, Gujarat, India.
BASIS OF ALLOTMENT
INITIAL PUBLIC OFFER CONSISTING OF FRESH ISSUE OF 29,61,000 EQUITY SHARES OF FACE VALUE OF RS. 10/- EACH FULLY PAID FOR CASH AT A PRICE OF RS.50/-PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS. 40/- PER EQUITY SHARE) (THE "ISSUE PRICE") AGGREGATING UPT0 RS. 1480.50 LAKHS (THE "ISSUE"), OF WHICH 1,53,000 EQUITY SHARES OF FACE VALUE OF RS. 10/- EACH FOR CASH AT A PRICE OF RS. 50/- PER EQUITY SHARE, AGGREGATING RS. 76.50 LAKHS WILL BE RESERVED FOR SUBSCRIPTION BY THE MARKET MAKER TO THE ISSUE (THE "MARKET MAKER RESERVATION PORTION"). THE ISSUE LESS MARKET MAKER RESERVATION PORTION I.E. ISSUE OF 28,08,000 EQUITY SHARES OF FACE VALUE OF RS. 10/- EACH FOR CASH AT A PRICE OF RS. 50/- PER EQUITY SHARE, AGGREGATING RS. 1404.00 LAKHS IS HEREINAFTER REFERRED TO AS THE "NET ISSUE". THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 27.01% AND 25.62% RESPECTIVELY OF THE FULLY DILUTED POST ISSUE PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY
THE FACE VALUE OF EQUITY SHARES IS RS. 10/- EACH.
RISKS TO INVESTORS:
I.Average cost of acquisition per Equity Share by our Promoters viz. Sanjay Shah is Rs.7.61, Rita Shah is Rs.10.00 and Aarsh Shah is Rs.10.00 and the Issue Price atthe upper end of the Price Band is significantly higher at Rs. 50 per Equity Share.
ISSUE OPENED ON: FRIDAY, SEPTEMBER 30, 2016 AND CLOSED ON: WEDNESDAY, OCTOBER 05, 2016.
In terms of Prospectus dated October 07, 2016 and as per Regulation 43(4) of SEBI (ICDR) Regulations, 2009 wherein
(a) minimum of 50% of the Net Offerto Public shall initially be made available to Retail Individual Investors.
(b) the balance net offer of shares to the public shall be made available for allotment to
(i) individual applicants otherthan retail investors and
(ii) other investors including corporate bodies/institutions irrespective of no. of shares applied for.
(c) the unsubscribed portion of the net offerto any one of the categories specified in
(a) or (b) shall/may be made available for allocation in any other category, if so
The Equity Shares offered through the Prospectus are proposed to be listed on EMERGE platform of National Stock Exchange of India Limited ("NSE") ("NSE EMERGE") in terms of the chapter XB of the SEBI (ICDR) Regulations, 2009 as amended from time to time. The Company has received an in principal approval letter dated September 21,2016 from National Stock Exchange of India Limited for using its name in the Prospectus for listing of our Shares on NSE EMERGE. The designated stock exchange is NSE EMERGE.
The Issue has received 719 applications for 48,60,000 Equity shares (Before Technical Rejections but after bids not banked and invalid duplicate bids) (including Market Maker Application of 1,53,000 Equity Shares) resulting 1.64 times subscription. After considering, Technical Rejection cases, bids not banked and Invalid duplicate bids, the issue was subscribed 1.62 times (including the Market Maker Portion).
The details of application received (Before Technical Rejection but after bids not banked and invalid duplicate bids)
The Basis of Allotment was Finalized in Consultation with the Designated Stock Exchange, being the EMERGE platform of NSE on Monday, October 10,2016 ALLOCATION: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange-NSE India Ltd on October 10,2016.
A. Allocation to Market Maker (After Technical Rejections): The Basis of Allotment to the Market Maker, at the issue price of Rs. 50/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 1.00 times. The total number of shares allotted in this category is 1,53,000 Equity shares in full out of reserved portion of 1,53,000 Equity Shares.
B. Allocation to Retail Individual Investors (After Technical Rejections): The Basis of Allotment to the Retail Individual Investors, atthe issue price of Rs. 50/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 1.38 times. Total number of shares allotted in this category is 14,04,000 Equity Shares. The category wise basis of allotment is as under:
C. Allocation to Other than Retail Individual Investor (After Technical Rejection): The Basis of Allotment to other than Retail Individual Investors, at the issue price of Rs 50/-per Equity Share, was finalized in consultation with National Stock Exchange of India Limited. The category was subscribed by 1.93 times. Total number of shares allotted in this category is 1,404,000 Equity Shares. The category wise basis of allotment is as under:
The Board of Directors of the Company at its meeting held on October 10,2016 has taken on record the Basis of Allocation of Equity Shares approved by the Designated Stock Exchange viz. National Stock Exchange of India Limited and authorized corporate action for allotment of shares in dematerializedform to various successful applicants. The CAN and allotment advice and/or notices shall be dispatched to the address of the Applicants as registered with the depositories / as filled in the application form on or before October 13,2016. Further, the instructions to SCSBs shall be issued on October 13,2016 for unblocking of funds. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. In case the same is not received within prescribed time, Investors may contact the registrarto the Issue atthe address given below. The Company is taking steps to get the Equity Shares admitted fortrading on the EMERGE Platform of NSE within six working days from the date of the closure of the Issue. The trading is proposed to commence on or before October 14,2016 subject to receipt of listing and trading approvals from NSE.
INVESTORS PLEASE NOTE
The details of the allotment made will be hosted on the website of the Registrar to the Issue at www.linkintime.co.in. All future correspondence in this regard may kindly be addressed to the Registrar quoting full name of the First/ Sole applicant, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details atthe address of the Registrar given below:
LINK INTIME INDIA PRIVATE LIMITED
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET
PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF SAKAR HEALTHCARE